Technical Analysis for HRTX - Heron Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 17.7 -1.09% -0.20
HRTX closed down 1.09 percent on Monday, October 14, 2019, on 59 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical HRTX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -1.09%
Inside Day Range Contraction -1.09%
50 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish -3.17%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.17%

Older signals for HRTX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
HRTX Chart by TradingView
Basic chart:
Profile
Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Medicine Health Pharmaceutical Clinical Medicine Oncology Chemotherapy Cancer Treatments Antineoplastic Drugs Occupational Safety And Health Drug Delivery Injectable Pharmaceuticals
Is HRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 7 Weekly CEO Buys Highlight
Oct 5 Bragar Eagel & Squire is Investigating Certain Officers and Directors of Healthcare Services Group, Heron Therapeutics, Immunomedics, and Karyopharm and Encourages Investors to Contact the Firm
Oct 4 Heron Therapeutics (HRTX) Investor Presentation - Slideshow
Oct 4 Healthcare - Top 5 Gainers / Losers
Oct 4 HPQ, HRTX among premarket losers
Oct 4 22 Stocks Moving in Friday's Pre-Market Session
Oct 4 The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering
Oct 4 How Heron Therapeutics, Inc. (NASDAQ:HRTX) Can Impact Your Portfolio Volatility
Oct 4 5 Stocks To Watch For October 4, 2019
Oct 4 Heron Therapeutics prices equity offering
See more HRTX news...
Indicators
Indicator Value
52 Week High 31.81
52 Week Low 15.68
Average Volume 1,023,361
200-Day Moving Average 21.3198
50-Day Moving Average 18.4631
20-Day Moving Average 18.9038
10-Day Moving Average 18.108
Average True Range 0.9945
ADX 16.19
+DI 14.3775
-DI 22.1609
Chandelier Exit (Long, 3 ATRs ) 18.7865
Chandelier Exit (Short, 3 ATRs ) 20.2335
Upper Bollinger Band 21.059
Lower Bollinger Band 16.7486
Percent B (%b) 0.22
BandWidth 22.801765
MACD Line -0.2996
MACD Signal Line -0.1241
MACD Histogram -0.1755
Fundamentals Value
Market Cap 958.24 Million
Num Shares 54.1 Million
EPS -4.15
Price-to-Earnings (P/E) Ratio -4.27
Price-to-Sales 59.70
Price-to-Book 11.60
PEG Ratio -0.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.35
Resistance 3 (R3) 18.41 18.25 18.24
Resistance 2 (R2) 18.25 18.09 18.22 18.20
Resistance 1 (R1) 17.98 17.99 17.90 17.92 18.17
Pivot Point 17.82 17.82 17.79 17.79 17.82
Support 1 (S1) 17.55 17.66 17.47 17.49 17.23
Support 2 (S2) 17.39 17.56 17.36 17.20
Support 3 (S3) 17.12 17.39 17.16
Support 4 (S4) 17.06